Inspire Medical Systems Q2 2024 Revenue Surges by 30%by Mark Eisenberg 07.08.2024Inspire Medical Systems reports a 30% revenue increase in Q2 2024, with net income of $9.8 million, and raises full-year ...
Eagle Point Income Q2 Performance Signals Strong Financial Healthby Mark Eisenberg 07.08.2024Eagle Point Income Company reports strong Q2 gains, with increased NAV and trading volume, signaling robust financial health.
Fraport AG Q2 2024 Earnings: Record High EBITDA and Revenue Growthby Mark Eisenberg 07.08.2024Fraport AG reports record EBITDA of €576 million and 13% revenue growth in Q2 2024, signaling robust financial performance.
Assurant’s Profit Soars on Strong Housing Unit and Investment Gainsby Mark Eisenberg 07.08.2024Assurant reports a 21% increase in Q2 profit driven by robust global housing performance and higher investment returns.
Olaplex Q2 Earnings: New Tech & Leadership Amid Sales Declineby Mark Eisenberg 07.08.2024Olaplex reports Q2 2024 earnings with $103.9M in sales, launches new curly hair tech, and adds two key execs, despite ...
Airbnb Stock Slumps Amid Weak Q3 Revenue Forecastby Mark Eisenberg 07.08.2024Airbnb shares drop 13% following a disappointing Q3 revenue forecast, despite beating Q2 revenue estimates. Consumer headwinds affect demand.
Thoma Bravo Eyes $2B Sale of ESG Software Leader Corityby Mark Eisenberg 06.08.2024Thoma Bravo seeks $2 billion valuation for ESG software maker Cority, engages Goldman Sachs for potential sale process.
Sempra’s Q2 Profit Up, Misses Revenue and Adjusted Earningsby Mark Eisenberg 06.08.2024"Sempra's Q2 profit surges due to record-high temperatures; clean energy investments and government policies drive future growth prospects."
Semler Scientific Q2 2024: Bitcoin Strategy and Earnings Revealedby Mark Eisenberg 06.08.2024"Semler Scientific Q2 2024: Strong operations despite 22% revenue dip, spotlight on Bitcoin investment as inflation hedge and strategic growth ...
Castle Biosciences Q2: Revenue Soars 74% to $87 Millionby Mark Eisenberg 06.08.2024Castle Biosciences reports 74% Q2 revenue surge to $87M, driven by test usage and price hikes, with net income rebounding ...